These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5810903)

  • 1. Secretory state. A positive prognostic sign in vitiligo.
    Sehgal VN; Dube B
    Dermatologica; 1969; 139(2):168-71. PubMed ID: 5810903
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral dosage in methoxsalen phototoxicity.
    Kligman AM; Goldstein FP
    Arch Dermatol; 1973 Apr; 107(4):548-50. PubMed ID: 4697683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Local treatment of vitiligo with Meladinine].
    Wiskemann A
    Hautarzt; 1973 May; 24(5):222. PubMed ID: 4753377
    [No Abstract]   [Full Text] [Related]  

  • 4. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of vitiligo with oral methoxsalen and UVA.
    Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
    Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo and methoxsalen.
    Sehgal VN
    Arch Dermatol; 1971 Mar; 103(3):343-4. PubMed ID: 5548288
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the treatment of vitiligo.
    el Mofty AM; Nada MM
    Int J Dermatol; 1971; 10(4):262-6. PubMed ID: 5114016
    [No Abstract]   [Full Text] [Related]  

  • 9. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease.
    Plettenberg H; Assmann T; Ruzicka T
    Arch Dermatol; 2003 May; 139(5):651-4. PubMed ID: 12756103
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 11. Ineffectiveness of trioxsalen as an oral photosensitizer.
    Kligman AM; Goldstein FP
    Arch Dermatol; 1973 Mar; 107(3):413-4. PubMed ID: 4692130
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some biochemical and chemotherapeutic aspects of vitiligo.
    Chakraborty DP
    Indian J Dermatol; 1966 Apr; 11(3):69-75. PubMed ID: 5945820
    [No Abstract]   [Full Text] [Related]  

  • 17. Childhood vitiligo: a prospective hospital-based study.
    Al-Mutairi N; Sharma AK; Al-Sheltawy M; Nour-Eldin O
    Australas J Dermatol; 2005 Aug; 46(3):150-3. PubMed ID: 16008644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment acquired vitiligo with Beroxan].
    Rudowska I
    Przegl Dermatol; 1969; 56(2):225-9. PubMed ID: 5790582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with Meladinin treatment of patients with vitiligo].
    Shalupenko VN
    Vrach Delo; 1966 Aug; 8():139-40. PubMed ID: 5989145
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?].
    Marcet B; Sibaud V; Géniaux M; Taieb A
    Ann Med Interne (Paris); 2002 Sep; 153(5):349-50. PubMed ID: 12442082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.